Exsilio is developing genomic medicines that insert therapeutic genes into safe harbors within the DNA. Backed by leading investors, we’re on a mission to transform the treatment of a broad range of diseases.

Our new website is coming soon. Feel free to contact us at info@exsiliotx.com.